HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nikola Gaidzik Selected Research

Synthetic Vaccines (Recombinant Vaccines)

1/2019Reduced Breast Tumor Growth after Immunization with a Tumor-Restricted MUC1 Glycopeptide Conjugated to Tetanus Toxoid.
5/2010Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the Toll-like receptor 2.
1/2009A synthetic vaccine consisting of a tumor-associated sialyl-T(N)-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response.
1/2008Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nikola Gaidzik Research Topics

Disease

7Neoplasms (Cancer)
01/2019 - 01/2008
2Breast Neoplasms (Breast Cancer)
01/2019 - 10/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2016
1Carcinoma (Carcinomatosis)
10/2011

Drug/Important Bio-Agent (IBA)

7GlycopeptidesIBA
01/2019 - 01/2008
4Synthetic Vaccines (Recombinant Vaccines)IBA
01/2019 - 01/2008
3Tetanus Toxoid (Vaccine, Tetanus)FDA Link
01/2019 - 01/2009
3AntigensIBA
01/2019 - 01/2008
2AntibodiesIBA
01/2019 - 10/2011
2Mucin-1 (CA 15-3 Antigen)IBA
01/2019 - 02/2016
2VaccinesIBA
02/2016 - 10/2011
2Monoclonal AntibodiesIBA
02/2016 - 01/2009
1Glycoproteins (Glycoprotein)IBA
01/2019
1Therapeutic UsesIBA
01/2019
1Tumor Viral Antigens (Large T Antigen)IBA
01/2019
1Neoplasm Antigens (Tumor Antigens)IBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1EpitopesIBA
01/2019
1Indicators and Reagents (Reagents)IBA
02/2016
1Biological ProductsIBA
02/2016
1Immunodominant EpitopesIBA
10/2011
1LipopeptidesIBA
05/2010
1LigandsIBA
05/2010
1Toll-Like Receptor 2IBA
05/2010
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2008

Therapy/Procedure

1Immunotherapy
02/2016